Greater awareness and increasing popularity among consumers to select drugs or food supplements exhibiting a clean label is a trend that producers are unable to ignore. The IMA Active laboratory explores...
Dr. Carmen Guguta, Technobis Crystallization Systems, explores how laboratories can do more complex experiments with small amounts of material by using benchtop analytical technology.
Daniel Samson, head of oligonucleotides at Bachem, gives some insight into the challenges faced when manufacturing on a large scale to meet growing demand.
Lonza's Giovanna Libralon, Small Molecules, and Iwan Bertholjotti, Bioconjugates, share insights on payload-linker manufacturing and the global market trends for ADC-based therapies, along with the antibodies that help increase the precision of ADCs.
Christina Smolke, PhD, co-founder and CEO of Antheia, describes how biomanufacturing can provide sustainable, high-quality APIs and KSMs, and de-risk pharmaceutical production by localising and streamlining supply chains.
LLS Health's experts, Joey Glassco, MBA, Injectable Drug Delivery, and Nick DiFranco, MEM, global market segment manager, share the API solubility puzzle that the pharma industry faces and how to solve it.
Lisa Caralli, Science and Technology director, Pharmaceutics, Catalent, discusses the methods that formulation scientists can undertake on small quantities of API to achieve the greatest possible results to progress through drug product development.
Mark Arnold, MD of ONFAB, part of Envair Technology, describes the challenges in handling HPAPIs and how pharma manufacturers can learn to manage the risk involved.
Anne-Cecile Bayne, global science & innovation lead Pharma & Medical Nutrition, DSM discusses the benefits of using antioxidants to block nitrosamine development in drug products, and futureproof pharma formulations.
Mike Brown, director and containment specialist at ONFAB - part of Envair Technology - explains the growing use of HPAPIs and the demand for flexible containment that this has created.
Karen Tyrrell, Quality Assurance Lead at Pfizer CentreOne discusses the key considerations around the classification and handling of active pharmaceutical ingredients.
